ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Geriatric Medicine

Top Geriatric Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PHILLIP IMMESOETE M.D.

Geriatric Medicine

40,821

$2.78M

687
282 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $57

FAROOQ AHMED M.D

Geriatric Medicine

15,945

$592K

507
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $57

GREGORY JOHNSON M.D.

Geriatric Medicine

14,037

$771K

371
346 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $57

ROBERT MOSS MD

Geriatric Medicine

12,658

$697K

435
430 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $57

JEROME DONNELLY DO

Geriatric Medicine

10,247

$512K

360
357 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $57

CHARLES LAGOSKI DO

Geriatric Medicine

9,406

$456K

318
295 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $57

AFSHAN HAFIZ AHMED MD

Geriatric Medicine

8,915

$396K

234
223 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $57

AZEEM AHSAN DO

Geriatric Medicine

8,265

$501K

345
223 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

32%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $57

ZOFIA CYGAN M.D.

Geriatric Medicine

7,723

$381K

231
215 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $57

THOMAS CORNWELL MD

Geriatric Medicine

7,167

$394K

292
247 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $57

OLAJUMOKE ADUBIFA M.D.

Geriatric Medicine

5,597

$260K

92
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $57

MELVIN GLICK MD

Geriatric Medicine

5,440

$275K

196
182 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $57

JACQUELINE WALKER MD

Geriatric Medicine

4,867

$293K

244
230 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $57

VASIREDDY BHOOPAL M.D.,

Geriatric Medicine

4,855

$449K

266
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $57

AARON LAZAR MD

Geriatric Medicine

4,781

$367K

169
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $57

LAURENCE HOGSTROM M.D.

Geriatric Medicine

4,461

$245K

286
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $57

RUSSELL MILLER MD

Geriatric Medicine

4,438

$214K

457
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $57

LIPING ZHANG M.D.

Geriatric Medicine

4,184

$239K

316
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $57

MICHAEL LIM M.D.

Geriatric Medicine

3,357

$316K

164
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 23%

$94
Average prescription price

Avg: $57

YAQUTA PATNI MD

Geriatric Medicine

3,103

$173K

209
153 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $57

ASHLEY MARTIN M.D.

Geriatric Medicine

2,783

$167K

229
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $57

J. ROMAINE ROBERTS MD

Geriatric Medicine

2,562

$135K

284
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $57

PAUL ROYAL-PRIEST

Geriatric Medicine

1,903

$103K

126
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $57

MAGDALENA BEDNARCZYK MD

Geriatric Medicine

1,591

$77.6K

148
142 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $57

CLAUDIO AGNE MD

Geriatric Medicine

731

$33.8K

16
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank